HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma

American Journal of Surgical Pathology

Volumn 34, Issue 7, 2010, Pages 1037-1042

  McCluggage, W Glenn ^a   Connolly, Lynnette ^a   McBride, Hilary A ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

aggressive angiomyxoma; HMGA2; vagina; vulva

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; TUMOR MARKER;

ARTICLE; BLOOD VESSEL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; METABOLISM; MYXOMA; PATHOLOGY; PREDICTION AND FORECASTING; VAGINA TUMOR; VASCULAR ENDOTHELIUM; VASCULARIZATION; VULVA TUMOR;

BLOOD VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MYXOMA; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 77954218289     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181e32a11     Document Type: Article

References (39)

1. Begin LR, Clement PB, Kirk ME, et al. Aggressive angiomyoma of pelvic soft parts: a clinicopathologic study of 9 cases. Hum Pathol. 1985;16:621-628.
2. Betz JL, Meloni AM, U'Ren LA, et al. Cytogenetic findings in a case of angiomyxoma of the vaginal wall. Cancer Genet Cytogenet. 1995; 84:157.
3. Blandamura S, Cruz J, Faure Vergara L, et al. Aggressive angiomyxoma: a second case of metastasis with patient's death. Hum Pathol. 2003;34:1072-1081.
4. Dal Cin P, Quade BJ, Neskey DM, et al. Intravenous leiomyoma-tosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosomes Cancer. 2003;36:205-206.
5. Fetsch JF, Laskin WB, Lefkowitz M, et al. Aggressive angiomyx-oma: a clinicopathologic study of 29 female patients. Cancer. 1996;78:79-90.
6. Fetsch JF, Laskin WB, Tavassoli FA. Superficial angiomyxoma (cutaneous myxoma): a clinicopathologic study of 17 cases arising in the genital region. Int J Gynecol Pathol. 1997;16:325-334.
7. Fine BA, Munoz AK, Litx LE, et al. Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist. Gynecol Oncol. 2001;81: 120-122.
8. Ganesan R, McCluggage WG, Hirschowitz L, et al. Superficial myofibroblastoma of the lower female genital tract: report of a series including tumours with a vulval location. Histopathology. 2005;46: 137-143.
9. Horman DE, Berean KW, Salski CB, et al. Aggressive angiomy-xoma of the pelvis: cytogenetic findings in a single case. Cancer Genet Cytogenet. 1991;56:130-131.
10. Iwasa Y, Fletcher CD. Cellular angiofibroma:clinicopathologic and immunohistochemical analysis of 51 cases. Am J Surg Pathol. 2004;28:1426-1435.
11. Iwasa Y, Fletcher CDM. Distinctive prepubertal vulval fibroma. A hitherto unrecognized mesenchymal tumor of prepubertal girls: analysis of 11 cases. Am J Surg Pathol. 2004;28:1601-1608.
12. Lam MM, Corless CL, Goldblum JR, et al. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol. 2006;25:288-292.
13. Laskin WB, Fetsch JF, Tavassoli FA. Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract. Hum Pathol. 2001;32:715-725.
14. McCluggage WG. A review and update of morphologically bland vulvovaginal mesenchymal lesions. Int J Gynecol Pathol. 2005;24: 26-38.
15. McCluggage WG. Recent developments in vulvovaginal pathology. Histopathology. 2009;54:156-173.
16. McCluggage WG, Patterson A, Maxwell P. Aggressive angiomyx-oma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol. 2000;53:603-605.
17. McCluggage WG, Ganesan R, Hirschowitz L, et al. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described. Histopathology. 2004;45:360-368.
18. McCluggage WG, Jamieson TJ, Dobbs SP, et al. Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin releasing hormone agonist therapy. Gynecol Oncol. 2006;100: 623-625.
19. McCluggage WG, Nielsen GP, Young RH. Massive vulval edema secondary to obesity and immobilization: a potential mimic of aggressive angiomyxoma. Int J Gynecol Pathol. 2008;27:447-452.
20. Medeiros F, Erickson-Johnson MR, Keeney GL, et al. Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower female genital tract. Genes Chromosomes Cancer. 2007;46:981-990.
21. Medeiros F, Oliveira AM, Lloyd RV, et al. HMGA2 expression as a biomarker for aggressive angiomyxoma. Mod Pathol. 2008;21:214A (abstract).
22. Meenakshi M, McCluggage WG. Myoepithelial neoplasms involving the vulva and vagina: report of four cases. Hum Pathol. 2009;40:1747-1753.
23. Micci F, Paanagopoulos I, Bjerkehagen B, et al. Deregulation of HMGA2 in an aggressive angiomyxoma with t(11;12) (q23;q15). Virchows Arch. 2006;448:838-842.
24. Newman PL, Fletcher CD. Smooth muscle tumours of the external genitalia: clinicopathological analysis of a series. Histopathology. 1991;18:523-529.
25. Nucci MR, Fletcher CD. Vulvovaginal soft tissue tumours: update and review. Histopathology. 2000;36:97-108.
26. Nucci MR, Granter SR, Fletcher CD. Cellular angiofibroma: a benign neoplasm distance from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol. 1997;21:636-644.
27. Nucci MR, Weremowicz S, Neskey DM, et al. Chromosomal translocation t(8;12) induced aberrant HMGIC expression in aggressive angiomyxoma of the vulva. Genes Chromosomes Cancer. 2001;32:172-176.
28. Nucci MR, Young RH, Fletcher CD. Cellular pseudosarcomatous fibroepithelial polyps of the lower female genital tract: an under-recognised lesion often misdiagnosed as sarcoma. Am J Surg Pathol. 2000;24:231-240.
29. O'Connell JX, Young RH, Nielsen JP, et al. Nodular fasciitis of the vulva: a study of six cases and literature review. Int J Gynecol Pathol. 1997;16:117-123.
30. Ostor AG, Fortune DW, Riley CB. Fibroepithelial polyps with atypical stromal cells (pseudosarcoma botryoides) of vulva and vagina. A report of 13 cases. Int J Gynecol Pathol. 1988;7: 351-360.
31. Rabban JT, Dal Cin P, Oliva E. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma. Int J Gynecol Pathol. 2006;25: 403-407.
32. Rawlinson NJ, West WW, Nelson M, et al. Aggressive angiomyx-oma with t(12;21) and HMGA2 rearrangment: report of a case and review of the literature. Cancer Genet Cytogenet. 2008;181: 119-124.
33. Siassi RM, Padapopoulos T, Matzel KE. Metastasizing aggressive angiomyxoma. N Engl J Med. 1999;341:1772.
34. Steeper TA, Rosai J. Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol. 1983;7:463-475.
35. Tallini G, Vanni R, Manfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest. 2000;80:359-369
36. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
37. Tsang WY, Chan JK, Lee KC, et al. Aggressive angiomyxoma. A report of four cases occurring in men. Am J Surg Pathol. 1992;16:1059-1065.
38. Vang R, Connelly JH, Hammill HA, et al. Vulvar hypertrophy with lymphedema. A mimicker of aggressive angiomyxoma. Arch Pathol Lab Med. 2000;124:1697-1699.
39. Vargas SA, Kozakewich HP, Boyd TK, et al. Childhood asymmetric labium majus enlargement mimicking a neoplasm. Am J Surg Pathol. 2005;29:1007-1016.